AAPL   330.76 (+2.62%)
MSFT   186.96 (+2.21%)
FB   230.61 (+1.91%)
CGC   16.51 (-0.72%)
BABA   219.49 (+0.67%)
MU   54.04 (+5.49%)
GE   7.90 (+2.07%)
TSLA   883.85 (+2.25%)
AMD   53.09 (+0.87%)
T   32.86 (+3.30%)
ACB   13.90 (-2.32%)
GILD   76.88 (-0.85%)
DIS   124.55 (+0.70%)
BAC   28.11 (+4.97%)
BA   205.09 (+11.28%)
AAPL   330.76 (+2.62%)
MSFT   186.96 (+2.21%)
FB   230.61 (+1.91%)
CGC   16.51 (-0.72%)
BABA   219.49 (+0.67%)
MU   54.04 (+5.49%)
GE   7.90 (+2.07%)
TSLA   883.85 (+2.25%)
AMD   53.09 (+0.87%)
T   32.86 (+3.30%)
ACB   13.90 (-2.32%)
GILD   76.88 (-0.85%)
DIS   124.55 (+0.70%)
BAC   28.11 (+4.97%)
BA   205.09 (+11.28%)
AAPL   330.76 (+2.62%)
MSFT   186.96 (+2.21%)
FB   230.61 (+1.91%)
CGC   16.51 (-0.72%)
BABA   219.49 (+0.67%)
MU   54.04 (+5.49%)
GE   7.90 (+2.07%)
TSLA   883.85 (+2.25%)
AMD   53.09 (+0.87%)
T   32.86 (+3.30%)
ACB   13.90 (-2.32%)
GILD   76.88 (-0.85%)
DIS   124.55 (+0.70%)
BAC   28.11 (+4.97%)
BA   205.09 (+11.28%)
AAPL   330.76 (+2.62%)
MSFT   186.96 (+2.21%)
FB   230.61 (+1.91%)
CGC   16.51 (-0.72%)
BABA   219.49 (+0.67%)
MU   54.04 (+5.49%)
GE   7.90 (+2.07%)
TSLA   883.85 (+2.25%)
AMD   53.09 (+0.87%)
T   32.86 (+3.30%)
ACB   13.90 (-2.32%)
GILD   76.88 (-0.85%)
DIS   124.55 (+0.70%)
BAC   28.11 (+4.97%)
BA   205.09 (+11.28%)
Log in

NASDAQ:WBAWalgreens Boots Alliance Stock Price, Forecast & News

$45.80
+1.60 (+3.62 %)
(As of 06/5/2020 03:21 PM ET)
Add
Compare
Today's Range
$44.30
Now: $45.80
$46.36
50-Day Range
$38.35
MA: $42.04
$46.38
52-Week Range
$36.65
Now: $45.80
$64.50
Volume383,036 shs
Average Volume6.94 million shs
Market Capitalization$40.18 billion
P/E Ratio11.74
Dividend Yield4.20%
Beta0.55
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. The company has a strategic partnership with Microsoft Corporation. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Read More
Walgreens Boots Alliance logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.7Dividend Strength: 5.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.51 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
Current SymbolNASDAQ:WBA
CUSIP93142210
Phone847-315-2500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$136.87 billion
Cash Flow$8.81 per share
Book Value$26.74 per share

Profitability

Net Income$3.98 billion

Miscellaneous

Employees342,000
Market Cap$40.18 billion
Next Earnings Date6/25/2020 (Estimated)
OptionableOptionable

Receive WBA News and Ratings via Email

Sign-up to receive the latest news and ratings for WBA and its competitors with MarketBeat's FREE daily newsletter.

Walgreens Boots Alliance (NASDAQ:WBA) Frequently Asked Questions

How has Walgreens Boots Alliance's stock been impacted by COVID-19 (Coronavirus)?

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, WBA shares have decreased by 0.6% and is now trading at $45.80. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Walgreens Boots Alliance?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating and 13 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Walgreens Boots Alliance.

When is Walgreens Boots Alliance's next earnings date?

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Thursday, June 25th 2020. View our earnings forecast for Walgreens Boots Alliance.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance Inc (NASDAQ:WBA) released its quarterly earnings data on Thursday, April, 2nd. The pharmacy operator reported $1.52 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.46 by $0.06. The pharmacy operator earned $35.82 billion during the quarter, compared to the consensus estimate of $35.24 billion. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The firm's quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.64 EPS. View Walgreens Boots Alliance's earnings history.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance declared a quarterly dividend on Wednesday, April 22nd. Shareholders of record on Wednesday, May 20th will be given a dividend of $0.4575 per share on Friday, June 12th. This represents a $1.83 dividend on an annualized basis and a yield of 4.00%. The ex-dividend date of this dividend is Tuesday, May 19th. View Walgreens Boots Alliance's dividend history.

What price target have analysts set for WBA?

14 brokerages have issued 12-month target prices for Walgreens Boots Alliance's shares. Their forecasts range from $42.00 to $61.00. On average, they expect Walgreens Boots Alliance's stock price to reach $50.23 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price. View analysts' price targets for Walgreens Boots Alliance.

Has Walgreens Boots Alliance been receiving favorable news coverage?

News headlines about WBA stock have been trending very negative this week, InfoTrie reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Walgreens Boots Alliance earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave media coverage about the pharmacy operator a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the next several days. View the latest news aboutWalgreens Boots Alliance.

Are investors shorting Walgreens Boots Alliance?

Walgreens Boots Alliance saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 16,700,000 shares, an increase of 35.2% from the April 30th total of 12,350,000 shares. Based on an average trading volume of 7,650,000 shares, the days-to-cover ratio is currently 2.2 days. Currently, 2.3% of the shares of the stock are sold short. View Walgreens Boots Alliance's Current Options Chain.

Who are some of Walgreens Boots Alliance's key competitors?

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), CVS Health (CVS), Intel (INTC), Walt Disney (DIS), Johnson & Johnson (JNJ), General Electric (GE), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV) and Exxon Mobil (XOM).

Who are Walgreens Boots Alliance's key executives?

Walgreens Boots Alliance's management team includes the following people:
  • Mr. James A. Skinner, Exec. Chairman (Age 75)
  • Mr. Stefano Pessina, Exec. Vice Chairman & CEO (Age 78)
  • Mr. James Kehoe, Global Controller, CAO, Exec. VP & Global CFO (Age 57)
  • Mr. Alexander W. Gourlay, Co-Chief Operating Officer (Age 59)
  • Ms. Ornella Barra, Co-Chief Operating Officer (Age 66)

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.73%), State Street Corp (5.32%), Franklin Resources Inc. (1.99%), Caisse DE Depot ET Placement DU Quebec (1.69%), Geode Capital Management LLC (1.31%) and JPMorgan Chase & Co. (1.03%). Company insiders that own Walgreens Boots Alliance stock include Kathleen Wilson-Thompson, Kimberly R Scardino, Marco Patrick Anthony Pagni, Nancy M Schlichting, Ornella Barra, Stefano Pessina and William C Foote. View institutional ownership trends for Walgreens Boots Alliance.

Which institutional investors are selling Walgreens Boots Alliance stock?

WBA stock was sold by a variety of institutional investors in the last quarter, including Capital International Investors, BlackRock Inc., Two Sigma Advisers LP, Canada Pension Plan Investment Board, American International Group Inc., Deutsche Bank AG, Franklin Resources Inc., and APG Asset Management N.V.. View insider buying and selling activity for Walgreens Boots Alliance.

Which institutional investors are buying Walgreens Boots Alliance stock?

WBA stock was bought by a variety of institutional investors in the last quarter, including Aristotle Capital Management LLC, APG Asset Management N.V., JPMorgan Chase & Co., Nuveen Asset Management LLC, Cullen Capital Management LLC, Kiltearn Partners LLP, Alberta Investment Management Corp, and Advisor Group Holdings Inc.. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Ornella Barra, and Stefano Pessina. View insider buying and selling activity for Walgreens Boots Alliance.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $45.80.

How big of a company is Walgreens Boots Alliance?

Walgreens Boots Alliance has a market capitalization of $40.18 billion and generates $136.87 billion in revenue each year. The pharmacy operator earns $3.98 billion in net income (profit) each year or $5.99 on an earnings per share basis. Walgreens Boots Alliance employs 342,000 workers across the globe.

What is Walgreens Boots Alliance's official website?

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.